Document is current

Any future updates will be listed below

Correction to: Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases

Crossref DOI link: https://doi.org/10.1007/s40262-022-01166-7

Published Online: 2022-08-17

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark